NASDAQ:RPTX
Repare Therapeutics Inc.
- Stock
Last Close
3.49
08/11 21:00
Market Cap
146.44M
Beta: 0.08
Volume Today
69.89K
Avg: 112.35K
PE Ratio
−3.26
PFCF: −2.48
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -1.40M - | -1.40M 0% | ||||||
average payables | 1.69M - | 2.19M 29.83% | 2.28M 4.00% | 1.38M 39.31% | 1.43M 3.55% | |||
average receivables | 2.06M - | 4.61M 123.79% | 4.70M 1.93% | 3.78M 19.59% | 4.41M 16.74% | |||
book value per share | -1.42 - | -1.99 40.31% | 14.31 819.41% | 7.63 46.70% | 6.67 12.57% | 0.01 99.92% | ||
capex per share | -0.07 - | -0.04 49.57% | -0.06 52.29% | -0.11 98.48% | -0.04 59.96% | -0.01 67.87% | -0.00 99.68% | |
capex to depreciation | -11.33 - | -1.43 87.36% | -2.16 50.47% | -2.49 15.70% | -1.15 53.93% | -0.30 73.51% | -0.99 226.38% | |
capex to operating cash flow | 0.19 - | 0.05 75.99% | 0.07 53.14% | 0.37 419.64% | 0.02 94.64% | -1.87 9,591.20% | 0.02 100.82% | |
capex to revenue | -16.57 - | -0.22 98.66% | -0.00 97.95% | |||||
cash per share | 0.68 - | 4.09 501.46% | 16.65 307.29% | 9.04 45.70% | 8.20 9.24% | 0.01 99.94% | ||
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 16.67K - | 155.32 99.07% | 11.97 92.29% | |||||
debt to assets | 0.01 - | 0.01 8.25% | 0.02 76.84% | 0.01 24.83% | 0.01 9.92% | |||
debt to equity | -0.02 - | 0.01 160.54% | 0.03 81.59% | 0.02 23.41% | 0.02 17.20% | |||
dividend yield | ||||||||
earnings yield | -0.02 - | -0.03 83.21% | -0.04 29.74% | -0.08 103.91% | -0.13 72.53% | -0.05 64.86% | -0.00 99.35% | |
enterprise value | 475.62M - | 620.59M 30.48% | 365.39M 41.12% | 470.47M 28.76% | 462.58M 1.68% | 307.17B 66,304.30% | ||
enterprise value over ebitda | -39.24 - | -23.43 40.28% | -6.81 70.93% | -4.34 36.36% | -23.01 430.72% | -2.64K 11,386.37% | ||
ev to operating cash flow | -37.69 - | -33.67 10.66% | -60.06 78.34% | -5.48 90.87% | 1.44K 26,297.89% | -2.42K 268.15% | ||
ev to sales | 2.71K - | 61.90 97.71% | 3.51 94.33% | |||||
free cash flow per share | -0.45 - | -0.84 84.29% | -0.85 1.77% | -0.42 51.21% | -2.31 457.29% | -0.01 99.71% | -0.00 54.08% | |
free cash flow yield | -0.01 - | -0.03 84.29% | -0.03 1.77% | -0.01 56.19% | -0.11 806.36% | -0.00 99.59% | -0.00 7.47% | |
graham net net | -1.57 - | -2.23 42.15% | 13.37 699.52% | 6.98 47.80% | 6.23 10.74% | 0.00 99.93% | ||
graham number | 5.37 - | 7.25 34.92% | 29.29 304.19% | 22.02 24.81% | 10.20 53.71% | 0.02 99.84% | ||
income quality | 0.77 - | 0.88 14.65% | 0.68 23.35% | 0.11 83.18% | 0.80 604.61% | -0.01 101.38% | 1.36 12,329.39% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 2.42 - | |||||||
interest debt per share | 0.05 - | 0.20 335.50% | 0.19 3.21% | -0.07 133.97% | 0.00 100.12% | |||
inventory turnover | ||||||||
invested capital | -0.02 - | 0.01 160.54% | 0.03 81.59% | 0.02 23.41% | 0.02 17.20% | |||
market cap | 486.35M - | 486.35M 0% | 714.33M 46.87% | 687.56M 3.75% | 797.58M 16.00% | 616.67M 22.68% | 307.28B 49,728.83% | |
net current asset value | -24.26M - | -50.25M 107.13% | 276.30M 649.82% | 271.12M 1.87% | 269.42M 0.63% | 201.87M 25.07% | ||
net debt to ebitda | 0.89 - | 3.54 299.77% | 6.01 69.71% | 3.01 49.81% | 7.66 154.27% | 0.93 87.89% | ||
net income per share | -0.49 - | -0.90 83.21% | -1.17 29.74% | -2.66 127.08% | -2.83 6.08% | -0.69 75.49% | -0.00 99.68% | |
operating cash flow per share | -0.38 - | -0.80 110.05% | -0.79 0.56% | -0.30 61.80% | -2.27 647.48% | 0.01 100.34% | -0.00 139.33% | |
payables turnover | ||||||||
receivables turnover | 0.02 - | 2.35 10,630.07% | 30.50 1,197.64% | |||||
research and ddevelopement to revenue | 296.97 - | 11.85 96.01% | 0.90 92.38% | |||||
return on tangible assets | -1.03 - | -0.27 74.16% | -0.15 43.55% | -0.29 93.83% | -0.08 72.48% | -0.37 363.03% | ||
revenue per share | 0.01 - | 0.20 2,884.00% | 3.14 1,464.80% | |||||
roe | 0.64 - | 0.59 7.54% | -0.19 131.56% | -0.37 99.03% | -0.10 71.96% | -0.44 325.59% | ||
roic | 0.57 - | 0.60 5.16% | -0.18 129.76% | -0.35 96.43% | -0.14 59.64% | -0.58 306.57% | ||
sales general and administrative to revenue | 106.27 - | 3.45 96.75% | 0.25 92.84% | |||||
shareholders equity per share | -1.42 - | -1.99 40.31% | 14.31 819.41% | 7.63 46.70% | 6.67 12.57% | 0.01 99.92% | ||
stock based compensation to revenue | 18.79 - | 1.69 91.02% | 0.15 91.15% | |||||
tangible asset value | -22.38M - | -46.13M 106.08% | 286.83M 721.80% | 288.42M 0.55% | 279.52M 3.09% | 212.08M 24.13% | ||
tangible book value per share | -1.42 - | -1.99 40.31% | 14.31 819.41% | 7.63 46.70% | 6.67 12.57% | 0.01 99.92% | ||
working capital | 10.14M - | 94.33M 829.96% | 335.54M 255.72% | 316.32M 5.73% | 275.36M 12.95% | 204.61M 25.69% |
All numbers in USD (except ratios and percentages)